Syndicate
NAMC Newswire

Press Releases
News Items
Articles
Event News
powered_by.png, 1 kB
Pharmaceutical Industry News
NAMCblue_small2.jpg
Filter     Order     Display # 
 Date Item Title
Tuesday, 29 July 2008 RNCOS Releases a New Report- Indian Pharma Sector Analysis
Thursday, 20 September 2007 ACADIA Pharmaceuticals To Take Part in UBS Conference
Wednesday, 22 August 2007 AnaSpec Introduces 28 New Catalog Antibodies
Sunday, 13 May 2007 New Cancer Drug Satraplatin Predicted To Reach the Market in Mid 2007 for Second-Line Treatment of P
Wednesday, 25 April 2007 Tietzs Applied Laboratory Medicine, 2nd Edition Book Is An Invaluable Resource For All Clinical Chem
Monday, 23 April 2007 Get the New Personalized Medicine Market Report 2007
Thursday, 05 April 2007 ACADIA Prices Public Offering
Tuesday, 03 April 2007 SuperGen Inc Closes Nipent Rights Sale
Sunday, 18 March 2007 Titan Pharmaceuticals Receives Financing
Friday, 23 February 2007 Cobalis Corp Receives Additional Funding
Wednesday, 14 February 2007 SIGA Technologies Launches Small Pox Drug Study
Wednesday, 14 February 2007 SIGA Technologies Launches Small Pox Drug Study
Saturday, 10 February 2007 Compugen Ltd To Showcase at GTCBio's Conference
Thursday, 08 February 2007 LaJolla Pharmaceutical To Showcase at BIO CEO Event
Tuesday, 06 February 2007 The South African Pharmaceutical Market is the Largest in Africa, Estimated at US$1,687 Million in 2
Monday, 05 February 2007 Targanta Therapeutics Makes New Appointments
Wednesday, 03 January 2007 IMPAX Laboratories Inc Trading Suspended by the SEC
Thursday, 28 December 2006 Hospira Inc to Showcase at JP Morgan Conference
Friday, 22 December 2006 Allergan Inc Receives FDA Approvable Letter
Saturday, 16 December 2006 Market Research available on CNS Drug Discoveries 2006: Schizophrenia
Tuesday, 05 December 2006 Specialist-Oriented Products Now Account for a Growing Share of Blockbuster Drugs
Monday, 04 December 2006 The Investors Corner: Cholesterol Drug Failure Weighs on Pfizer Inc
Saturday, 18 November 2006 Bentley Pharmaceuticals, Inc Recognized By Forbes
Thursday, 09 November 2006 BioSante Pharmaceuticals, Inc Inks Deal with Bradley Pharmaceuticals, Inc
Wednesday, 08 November 2006 Saudi Arabian Pharmaceuticals Market One of the Richest in the Middle East but Still Facing Some Cha
Friday, 27 October 2006 Technological Developments Set to Drive Growth for Industrial Enzymes
Tuesday, 24 October 2006 Gain a Broad Perspective on Deal Making in Biopharma
Monday, 23 October 2006 AMDL, Inc. Updates Corporate Website
Thursday, 19 October 2006 View Leading Players in the Global Anticoagulants Market
Thursday, 19 October 2006 Wal-Mart Brings Affordable Generic Prescription Program to New Jersey
Friday, 13 October 2006 Avalon Pharmaceuticals Adds Board Member
Tuesday, 26 September 2006 If Approved In Early 2008, New Research Expects That Renovis and Astrazenecas NXY-059 Would Be Rapid
Thursday, 14 September 2006 Antares Pharma, Inc to Present at UBS Conference
Tuesday, 05 September 2006 Global Drug Sales and Growth Forecasts in Major Therapeutic Areas: 2002-2009
Saturday, 02 September 2006 View Detailed P&L and Investment Review of the Latest Full Year Performance for Abbott Laboratories
Friday, 18 August 2006 All Sectors Except Digestive Remedies Experienced Growth in the German OTC Market
Monday, 03 July 2006 Strategic Insights Help Pharmaceutical Companies Develop a Detailed Understanding of How the Introdu
Tuesday, 13 June 2006 Gain an Insight into How the Analgesics Market in the UK is Set to Change
Thursday, 08 June 2006 Akorn Inc Gets New Drug Application Approval
Monday, 29 May 2006 Pharmaceutical Companies in the Netherlands are Experiencing Slow Progress within the Area of Biotec
Saturday, 06 May 2006 Nymox Pharmaceutical Gets CE Mark
Tuesday, 25 April 2006 How Can Microarray Tools and Technologies Facilitate Drug Discovery, Design and Development?
Saturday, 22 April 2006 Nymox Pharmaceutical Corporation Review of Safety Data for New Drug
Sunday, 16 April 2006 Generic Growth Opportunities are Significant
Friday, 07 April 2006 The Suggestion That Pharmaceutical Companies Should Restructure Costs to Focus More Spending On R&D
Monday, 03 April 2006 Peregrine Pharmaceuticals Shows Strong Potential for Tarvacin
Monday, 03 April 2006 Pharmacopeia Enters into Exclusive Licensing Agreement with Bristol-Myers Squibb
Friday, 31 March 2006 Peregrine Pharmaceuticals Files 15 Million Share Shelf Registration Statement
Monday, 27 March 2006 Encysive Pharmaceuticals Stock Drops on FDA Delay
Saturday, 25 March 2006 Between 2010 and 2015 the Therapeutic Lung Cancer Drug Market is Expected to be Worth over $4 billio
 
<< Start < Prev 1 2 Next > End >>
Results 1 - 50 of 68



NAMC Newswire
 (c) NAMC Newswire
Issuers of news releases and not NAMC are solely responsible for the accuracy of the content